IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 108 filers reported holding IGM BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,815,891 | -38.5% | 456,993 | -32.0% | 0.00% | 0.0% |
| Q2 2023 | $6,204,304 | +14.7% | 672,189 | +70.8% | 0.00% | 0.0% |
| Q1 2023 | $5,406,882 | +59.8% | 393,514 | +97.8% | 0.00% | 0.0% |
| Q4 2022 | $3,383,731 | -40.3% | 198,926 | -20.2% | 0.00% | 0.0% |
| Q3 2022 | $5,668,000 | +58.4% | 249,269 | +25.5% | 0.00% | 0.0% |
| Q2 2022 | $3,579,000 | -68.7% | 198,554 | -53.6% | 0.00% | -50.0% |
| Q1 2022 | $11,443,000 | -3.3% | 428,087 | +6.1% | 0.00% | 0.0% |
| Q4 2021 | $11,838,000 | -55.7% | 403,624 | -0.7% | 0.00% | -66.7% |
| Q3 2021 | $26,730,000 | -24.0% | 406,480 | -3.9% | 0.01% | -25.0% |
| Q2 2021 | $35,184,000 | -38.0% | 422,883 | -42.9% | 0.01% | -42.9% |
| Q1 2021 | $56,775,000 | +213.2% | 740,310 | +260.6% | 0.01% | +180.0% |
| Q4 2020 | $18,127,000 | +309.0% | 205,318 | +241.9% | 0.01% | +400.0% |
| Q3 2020 | $4,432,000 | -6.1% | 60,054 | -7.1% | 0.00% | 0.0% |
| Q2 2020 | $4,719,000 | +386.0% | 64,645 | +18.2% | 0.00% | – |
| Q3 2019 | $971,000 | – | 54,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $97,797,000 | 2.22% |
| Artal Group S.A. | 1,500,000 | $43,995,000 | 1.19% |
| Cormorant Asset Management, LP | 500,000 | $14,665,000 | 0.87% |
| Eagle Bay Advisors LLC | 34,835 | $1,022,000 | 0.65% |
| ENTRUST GLOBAL PARTNERS L L C | 66,172 | $1,940,000 | 0.54% |
| Baker Brothers Advisors | 3,156,102 | $92,568,000 | 0.45% |
| Bruce & Co., Inc. | 55,000 | $1,613,000 | 0.32% |
| Woodline Partners LP | 403,401 | $11,832,000 | 0.17% |
| Virtus ETF Advisers LLC | 5,787 | $170,000 | 0.06% |
| Alkeon Capital Management | 939,035 | $27,542,000 | 0.05% |